NACDS submitted comments to the Board of Pharmacy on a proposed rule modifying the requirements for reporting to the state’s prescription drug monitoring program (PDMP). Specifically, NACDS asked the Board to clarify that pharmacies are required to submit a patient’s phone number as the patient identifier where it is available. Additionally, NACDS asked the Board to change a requirement that pharmacies notify the Board of PDMP submission errors to requiring such a notification only where the submission error cannot be corrected within seven days.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.